TrialEuropean journal of drug metabolism and pharmacokinetics2020

Pharmacokinetic and Pharmacodynamic Studies of Elacestrant, A Novel Oral Selective Estrogen Receptor Degrader, in Healthy Post-Menopausal Women.

Maureen G Conlan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.